Home
Product
Overview
Adenosine Receptor Antagonists
JAK Inhibitors
BTK Inhibitors
Glucokinase Receptor Activator
Early Stage Programs
About Us
Investor Relations
Contact Us
ANNUAL REPORTS
Annual Report – FY 2023-24
[PDF]
Annual Return – FY 2023-24
[PDF]
Annual Return – FY 2022-23
[PDF]
Policies
CSR Policy
[PDF]
CSR Projects – FY 2023-24
[PDF]